Glucagon-like peptide 1 receptor agonists and sodium glucose co-transporter 2 inhibitors as combination therapy for type 2 diabetes. A systematic review and meta-analysis (Q96020204)
Jump to navigation
Jump to search
scientific article published on 01 June 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Glucagon-like peptide 1 receptor agonists and sodium glucose co-transporter 2 inhibitors as combination therapy for type 2 diabetes. A systematic review and meta-analysis |
scientific article published on 01 June 2020 |
Statements
Glucagon-like peptide 1 receptor agonists and sodium glucose co-transporter 2 inhibitors as combination therapy for type 2 diabetes. A systematic review and meta-analysis (English)
Panagiota Kakotrichi
Konstantinos Malandris